NLARx Newsletter Header
NLARx News
April 26, 2010
In This Issue
NLARx on Facebook
Save the Date
Outrage of the Week
News from the States
Pharmaceutical Pricing
Health Reform
Conflicts of Interest
Advertising & Marketing
Pharma Watch
PBM Watch
Patents & Generics
Medicare & Medicaid
Safety & Clinical Trials
Fellowship
Quick Links
Join Our Mailing List
NLARx on Facebook!
For up-to-the-minute posting of news of interest and events, become a fan of NLARx on Facebook here!
Save the Date!
October 1-12, 2010: 2010 International Symposium on Safe Medicine.  Call for proposals, films, and exhibitors coming soon!
Outrage of the Week
Allergan Seeks $460K From A Defeated Plaintiff more
News from the States
California: Data Mining Bill Shelved more
Connecticut: House Unanimously Passes Prescription Pooling Bill more
Florida: State Finds 'Dramatic' Difference In Medicaid HMOs Vs. Traditional Care more
Miami-Dade Clinic Operator Pleads Guilty to Medicare Fraud more
Kansas: Small Medicaid Cuts Have Big Impact On Some Seniors more
Maryland: O'Malley Signs Bills To Mark End Of Session more
New York: Investigators Raid Senate Official's Office, Seeking Medicare, Medicaid Fraud Evidence more
North Dakota: Pharmacy Change Advocates Gather Signatures for Statewide Vote more
Vermont: Drug Samples Thorny Issue at Statehouse more
Pharmaceutical Pricing
Drugmakers Raised Prices Last Year In Anticipation Of New Health Law, Eli Lilly Reports Financial Hit more
Lilly's Health-Care Costs Set Stage for Drugmakers more
Drug Prices Rose 9.1% Last Year, Ahead of Federal Health Overhaul more
Pharma Sales Set to Grow 5%-8%; Overhaul Effects Unclear more
Pharmaceuticals & Health Reform
Senator Dorgan, Gov Schweitzer Push for North Dakota-Montana Pilot Importation Program more
CMS Guidance on Changes to Medicaid Drug Rebates in Reform Bill more
When Will the Health Care Law Lower Drug Costs? more
Medicare Advantage Competitive Pricing: The Political Failure Of A Good Idea more
Congressional Leaders Successfully Urge Use of Economic Stimulus for Academic Detailing more
Comparative Effectiveness Funds Spur Changes, But Not Without Critics more
Conflict of Interest & Disclosure
Study Sees a Slant in Articles on Drug more
Data on Fees to Doctors Is Called Hard to Parse more
Medical Groups Adopt Stricter Ethics Code Against Conflicts Of Interest more
Physician Groups Adopt New Ethics Code more
FDA Proposes New Disclosure Rules For Panels more
Advertising and Marketing
Pfizer And Neurontin: Which Witch Is Which? more
Academic Detailing and the Odds at Agincourt more
Coupon Culture Extends to Prescription Meds more
Pharma Watch
Pharma Debt Is Outstripping Growth In Cash more
Feds Consider Banning Execs For Fraud more
Merck Hid Vioxx's Risks From Louisiana, Official Says more
Genzyme Expects a Fine of $175 Million more
Elan Considers EDT Spinoff more
UK Sentences Former J&J Exec For Corruption more
The World's Biggest-Selling Drug In 2014 Will Be... more
PBM Watch
CVS Caremark Insider Sales Prompt Activists To Seek SEC Probe more
Retail Clinics: CVS to Double Presence, Walgreens Seeks Partners more
Mail-Order Drug Provider Identifies $163B In Potential Prescription Drug Savings more
UnitedHealth Doubles Co-Pay For Merck's Vytorin more
Patents and Generics
Merck Loses Patent Ruling Over Zetia more
Think Gene Patents Are Controversial Now? Just Wait more
Rivalry Heats Up for Bayer, Teva as The Pill Turns 50 more
Medicare and Medicaid
New Rules on Medicaid Discounts a Bummer for States more
F.B.I. Raids Bronx Clinic Office Linked to Espada more
State's Medicaid Funds Tapped For Federal Health Overhaul more
Boehringer-Ingelheim Pays $8M To Settle Fraud more
States' Medicaid Funds Tapped For Federal Health Overhaul more
Mississippi Can Sue Bayer For Medicaid Fraud more
Aetna Hit With Penalty, Suspended From Signing Up New Medicare Members more
Safety and Clinical Trials
Kids' Suicide Risk Is Same For All Antidepressants more
Role of Patients Social Networks more
Lilly's ImClone Chops Drug Safety Jobs more
Health Record Push Lacks FDA Oversight, Risks Safety Problems more
FDA Warns of Liver Risks in Warning on Overactive-Thyroid Drug more
The FDA May Halt The Avandia Safety Study more
Those FDA Warning Letters To Glaxo & Novartis more
Cancer Clinical Trials Are In A 'State Of Crisis' more
Cancer Research by U.S. Disorganized, Underfunded, Study Says more
Patients Scramble for Relief in Face of Genzyme Drug Shortage more
Report Stresses Safety Risks to Americans from Chinese-Made Drug Ingredients more
Genzyme Drug Shortage Leaves Users Feeling Betrayed more
Popular Anticonvulsants Raise Suicide Risks: Study more
Fellowship Opportunity
Australian-American Health Policy Fellowship more